Skip to search formSkip to main contentSkip to account menu

Recurrent Lung Adenocarcinoma

Known as: Lung Adenocarcinoma, Recurrent, Recurrent Adenocarcinoma of Lung, Recurrent Adenocarcinoma of the Lung 
The re-emergence of lung adenocarcinoma after a period of remission.
National Institutes of Health

Related topics

Related topics

27 relations
ALK geneChestChromosome 13q deletionCoughing

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Impact of the epidermal growth factor receptor mutation status on the prognosis of recurrent adenocarcinoma of the lung after curative surgery
The prognosis of patients with epidermal growth factor receptor (EGFR) mutant adenocarcinoma of the lung (Mt) and EGFR wild-type… 
2017
2017
Progressive hypoventilation due to mixed CD8+ and CD4+ lymphocytic polymyositis following tremelimumab - durvalumab treatment
Background The combination of CTLA-4 and PD-L1 inhibitors has a manageable adverse effect profile, although rare immune-related… 
2016
2016
Successful retreatment with osimertinib after osimertinib-induced acute pulmonary embolism in a patient with lung adenocarcinoma: A case report
2013
2013
[Efficacy of low-dose erlotinib against gefitinib-induced hepatotoxicity in a patient with lung adenocarcinoma harboring EGFR mutations].
We report a case of a female in her 80s who was diagnosed with recurrent lung adenocarcinoma after primary surgery. She was… 
2012
2012
New EGFR-TKI: a case report of recurrent lung adenocarcinoma successfully treated with icotinib.
Icotinib is a new oral epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI). We report on a 49-year-old man… 
2012
2012
[A case of alpha-fetoprotein-producing recurrent lung adenocarcinoma successfully treated with radiation therapy(high-grade adenocarcinoma of fetal lung type)].
A 71-year-old woman with a high serum α-fetoprotein (AFP) level was closely examined systemically, and a solid nodule was… 
2011
2011
[Renal-salt wasting syndrome in a patient with CDDP containing chemotherapy for recurrent non-small-cell lung cancer].
Hyponatremia is one of the major side effects that occurs after CDDP-based cancer chemotherapy. However, RSWS has rarely been… 
Review
2008
Review
2008
The characteristics and failure pattern of gefitinib responders with postoperative recurrence of pulmonary adenocarcinoma.
2006
2006
Thai female non-smoker with recurrent lung adenocarcinoma who has dramatic and prolonged response to gefitinib for over one year.
A 53-year old non-smoking Thai female was diagnosed with metastatic non-small cell lung cancer to bone. The initial biopsy from… 
1989
1989
STUDY OF CEA DOUBLING TIME OF RECURRENT LUNG ADENOCARCINOMA
We calculated the CEA doubling time of recurrent lung adenocarcinoma (35 cases) and studied the factors influencing the growth… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)